Reactivation of Silenced WT1 Transgene by Hypomethylating Agents - Implications for in vitro Modeling of Chemoimmunotherapy

由 Kwon, Yong-Rim, Son, Min-Jung, Kim, Hye-Jung, Kim, Yoo-Jin
出版 2012

Enhanced differentiation of mesenchymal stromal cells by three-dimensional culture and azacitidine

由 Bae, Yoo-Jin, Kwon, Yong-Rim, Kim, Hye Joung, Lee, Seok, Kim, Yoo-Jin
發表在 Blood Res (2017)

Enhanced polo-like kinase 1 expression in myelodysplastic syndromes

由 Min, Kyoung Il, Park, Silvia, Shin, Seung-Hwan, Kwon, Yong-Rim, Kim, Hye-Joung, Kim, Yoo Jin
發表在 Blood Res (2019)

Epigenetic modification of mesenchymal stromal cells enhances their suppressive effects on the Th17 responses of cells from rheumatoid arthritis patients

由 Kim, Kyoung-Woon, Kim, Hye Joung, Kim, Bo-Mi, Kwon, Yong-Rim, Kim, Hae-Rim, Kim, Yoo-Jin
發表在 Stem Cell Res Ther (2018)

Gene expression signatures associated with sensitivity to azacitidine in myelodysplastic syndromes

由 Kim, Kyuryung, Park, Silvia, Choi, Hayoung, Kim, Hye Joung, Kwon, Yong-Rim, Ryu, Daeun, Kim, Myungshin, Kim, Tae-Min, Kim, Yoo-Jin
發表在 Sci Rep (2020)

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells

由 Kwon, Yong-Rim, Kim, Hye Joung, Sohn, Min-Jung, Lim, Ji-Young, Park, Kyung-Shin, Lee, Seok, Chung, Nack-Gyun, Jeong, Dae-Chul, Min, Chang-Ki, Kim, Yoo-Jin
發表在 Exp Hematol Oncol (2020)

Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome

由 Jung, Seung-Hyun, Kim, Yoo-Jin, Yim, Seon-Hee, Kim, Hye-Jung, Kwon, Yong-Rim, Hur, Eun-Hye, Goo, Bon-Kwan, Choi, Yun-Suk, Lee, Sug Hyung, Chung, Yeun-Jun, Lee, Je-Hwan
發表在 Oncotarget (2016)